We are live on ! Find out more
SGM

Seven Grand Managers Portfolio holdings

AUM $1.5B
1-Year Est. Return 57.16%
This Fund
S&P 500
This Quarter Est. Return
+11.24%
1 Year Est. Return
+57.16%
3 Year Est. Return
+233.02%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.5B
AUM Growth
+$183M
Cap. Flow
+$155M
Cap. Flow %
10.34%
Top 10 Hldgs %
42.84%
Holding
214
New
76
Increased
20
Reduced
18
Closed
47

Top Buys

1
LHX icon
L3Harris
LHX
+$96.1M
2
MDLN
Medline Inc
MDLN
+$59.6M
3
LRCX icon
Lam Research
LRCX
+$59M
4
ECHO
EchoStar
ECHO
+$57.4M
5
TSLA icon
Tesla
TSLA
+$53.6M

Top Sells

1
SNDK
Sandisk
SNDK
+$84.7M
2
TMUS icon
T-Mobile US
TMUS
+$40.6M
3
SOFI icon
SoFi Technologies
SOFI
+$39.3M
4
MDT icon
Medtronic
MDT
+$38.4M
5
COHR icon
Coherent
COHR
+$36.9M

Sector Composition

1 Industrials 23.49%
2 Healthcare 18.53%
3 Technology 17.09%
4 Energy 11.6%
5 Consumer Discretionary 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALHC icon
101
Alignment Healthcare
ALHC
$4.14B
$2.64M 0.18%
+150,000
New +$3.01M
BGSI
102
Boyd Group Services
BGSI
$2.87B
$2.56M 0.17%
20,000
– –
KYMR icon
103
Kymera Therapeutics
KYMR
$9.38B
$2.5M 0.17%
30,000
– –
AXGN icon
104
Axogen
AXGN
$2.12B
$2.48M 0.17%
+75,000
New +$2.44M
GPCR icon
105
Structure Therapeutics
GPCR
$3.27B
$2.41M 0.16%
50,000
– –
CBC
106
Central Bancompany Inc
CBC
$7.68B
$2.4M 0.16%
100,000
– –
IRON icon
107
Disc Medicine
IRON
$2.81B
$2.24M 0.15%
35,000
– –
RLMD icon
108
Relmada Therapeutics
RLMD
$573M
$2.2M 0.15%
+315,788
New +$1.49M
NTSK
109
Netskope Inc
NTSK
$5.45B
$2.12M 0.14%
250,000
-225,000
-47% -$2.79M
AERO
110
Grupo Aeromexico SAB de CV
AERO
$2.32B
$2.1M 0.14%
150,000
– –
AGMB
111
AgomAb Therapeutics NV
AGMB
$607M
$2.1M 0.14%
+200,000
New +$2.83M
MPLT
112
MapLight Therapeutics
MPLT
$1.69B
$2.03M 0.14%
100,000
– –
SION
113
Sionna Therapeutics
SION
$2.04B
$2M 0.13%
50,000
– –
KPET.U
114
KPET Ultra Paceline Corp Units
KPET.U
$2M 0.13%
+200,000
New +$2M
SYM icon
115
Symbotic
SYM
$5.34B
$2M 0.13%
37,500
-37,500
-50% -$2.15M
KMTS
116
Kestra Medical Technologies
KMTS
$1.41B
$1.99M 0.13%
100,000
– –
BLLN
117
BillionToOne Inc
BLLN
$5.9B
$1.97M 0.13%
25,000
– –
ZBIO
118
Zenas BioPharma
ZBIO
$1.78B
$1.96M 0.13%
+100,000
New +$2.24M
PTRN
119
Pattern Group Inc
PTRN
$5.11B
$1.86M 0.12%
150,000
– –
AVR
120
Anteris Technologies
AVR
$812M
$1.8M 0.12%
+325,000
New +$1.87M
BOBS
121
Bobs Discount Furniture
BOBS
$2.16B
$1.76M 0.12%
+150,000
New +$2.56M
KNTK icon
122
Kinetik
KNTK
$3.67B
$1.69M 0.11%
+35,000
New +$1.49M
CMPS
123
Compass Pathways
CMPS
$1.68B
$1.66M 0.11%
+300,000
New +$2.02M
OFRM
124
Once Upon a Farm PBC
OFRM
$768M
$1.64M 0.11%
+100,000
New +$2.06M
ERAS icon
125
Erasca
ERAS
$6.6B
$1.62M 0.11%
+100,000
New +$1.18M
3 4
5
6 7

Similar funds

CPA
Capital Performance Advisors Walnut Creek, California $1.5B AUM 21.4% 1-Year Est. Return
NPF
Norris Perne & French Grand Rapids, Michigan $1.5B AUM 19.93% 1-Year Est. Return
RCW
Rheos Capital Works Tokyo, Japan $1.5B AUM 47.78% 1-Year Est. Return
MCM
Maple Capital Management Montpelier, Vermont $1.49B AUM 23.46% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
SB
Simmons Bank Pine Bluff, Arkansas $1.49B AUM 23.32% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
AAM
Aureus Asset Management Boston, Massachusetts $1.5B AUM 20.3% 1-Year Est. Return

Seven Grand Managers's Q1 2026 Portfolio in Review

As of Q1 2026, Seven Grand Managers held 214 positions worth $1.5B, up 14% from $1.31B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Seven Grand Managers deployed $155M of net new capital in Q1 2026, opening 76 new positions and adding to 20 existing holdings. Its largest new stake was L3Harris: 275,000 shares worth $94.9M.

By sector, the portfolio is most concentrated in Industrials at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Sandisk, an estimated $84.7M trimmed.

  • Seven Grand Managers's largest Q1 2026 buy was L3Harris: 275,000 shares worth $94.9M.
  • Seven Grand Managers added most to Medline Inc in Q1 2026, an estimated $59.6M increase.
  • Seven Grand Managers's biggest Q1 2026 reduction was Sandisk, cutting an estimated $84.7M.
  • Seven Grand Managers fully exited T-Mobile US in Q1 2026, selling an estimated $40.6M.
  • Seven Grand Managers's ten largest holdings make up 43% of its $1.5B portfolio in Q1 2026.
  • Seven Grand Managers opened 76 new positions and closed 47 in Q1 2026.
  • Seven Grand Managers's portfolio value rose 14% quarter-over-quarter to $1.5B.

Based on Seven Grand Managers's 13F filing for Q1 2026, filed 6 May 2026.